Back to top

Latest News

29 January 2014

Carer mobilises community behind Multiple Sclerosis Treatment

Sunbury carer and mother of three Brenda Fisher, has secured more than 10,000 signatures supporting improved treatment choices for people with Multiple Sclerosis (MS).

Brenda, whose husband Mark was diagnosed with MS more than 18 years ago, has rallied the community behind her call for...

29 January 2014

Carer mobilises community behind Multiple Sclerosis Treatment

Sunbury carer and mother of three Brenda Fisher, has secured more than 10,000 signatures supporting improved treatment choices for people with Multiple Sclerosis (MS).

Brenda, whose husband Mark was diagnosed with MS more than 18 years ago, has rallied the community behind her call for...

17 January 2014

Public submissions now open for Pharmacuetical Benefits Advisory Committee March meeting

The public commentary period for the next round of Pharmaceutical Benefits Advisory Committee (PBAC) considerations is now open.

MS treatment Fampyra -produced by Biogen Idec - is being considered for subsidisation by the Federal Government through the PBAC this March.

Fampyra (...

17 January 2014

Sharing news of a diagnosis could be key to people with MS retaining employment

Researchers have discovered that people with Multiple Sclerosis (MS) may be better off disclosing their diagnosis to their employer rather than staying quiet about their MS.

Dr Pieter Van Dijk and Dr Andrea Kirk-Brown from Monash University, in collaboration with Dr Rex Simmons from...

20 November 2013

Collaroy couple awarded highest MS Australia accolade

Two fundraisers from Sydney’s Northern Beaches have been formally recognised for their years of service improving the lives of people affected by Multiple Sclerosis (MS).

Carol Langsford (OAM) and Roy Langsford (OAM), founders of the Trish MS Research Foundation have been awarded the John...

20 November 2013

Collaroy couple awarded highest MS Australia accolade

Two fundraisers from Sydney’s Northern Beaches have been formally recognised for their years of service improving the lives of people affected by Multiple Sclerosis (MS).

Carol Langsford (OAM) and Roy Langsford (OAM), founders of the Trish MS Research Foundation have been awarded the John...

27 August 2013

PBAC recommendations deliver promising news for people with MS

Multiple Sclerosis Australia (MSA) has welcomed the recent Pharmaceutical Benefits Advisory Committee (PBAC) recommendations of not one, but two oral multiple sclerosis (MS) medications.

27 August 2013

PBAC recommendations deliver promising news for people with MS

Multiple Sclerosis Australia (MSA) has welcomed the recent Pharmaceutical Benefits Advisory Committee (PBAC) recommendations of not one, but two oral multiple sclerosis (MS) medications.

1 August 2013

National MS Advocates Co-ordinator Robert Pask nominated as a finalist for the National Disability Awards

A big congratulations to our National MS Advocates Co-ordinator Robert Pask who has been nominated as a finalist in this year's National Disability Awards.

Robert has been recognised for his work in establishing the National MS Advocates Program and his commitment to supporting the needs...

26 April 2013

Landmark Melbourne Tower to Transform Lives For People With Disabilities

MS Australia - ACT/NSW/VIC and Young People in Nursing Homes National Alliance (YPINH) today welcomed the Federal Government's commitment to the construction of a landmark new tower to be built in the heart of Melbourne's CBD.

When completed the 'Cairo' building will include 220...

13 September 2012

CEO/Implementation Executive Announced For MS Australia

The Board of MS Australia is delighted to announce the appointment of respected former MS Queensland CEO Trevor Farrell as the organisation’s Chief Executive Officer and Implementation Executive.

24 August 2012

Research Into Theories On Multiple Sclerosis

A segment on the ABC’s Catalyst program last night reported on several investigations into theories about the cause of multiple sclerosis (MS) and possible future treatments. The report particularly looked at the theories of Chlamydia Pneumonia (CP) and Chronic Cerebospinal Venous Insufficiency...

Pages